A novel capsid-modified oncolytic recombinant adenovirus type 5 for tumor-targeting gene therapy by intravenous route

Oncolytic adenovirus (Ad)-vectored gene therapy is a promising strategy for cancer treatment. However, the lack of cancer cell selectivity or tumor tissue specificity of Ads limits their clinical application by intravenous (IV) injection. In this paper, a novel recombinant Ad5 vector was constructed...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhen, Yu, Bin, Wang, Baoming, Yan, Jingyi, Feng, Xiao, Wang, Zixuan, Wang, Lizheng, Zhang, Haihong, Wu, Hui, Wu, Jiaxin, Kong, Wei, Yu, Xianghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216942/
https://www.ncbi.nlm.nih.gov/pubmed/27323824
http://dx.doi.org/10.18632/oncotarget.10075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216942/
https://www.ncbi.nlm.nih.gov/pubmed/27323824
http://dx.doi.org/10.18632/oncotarget.10075

Ejemplares similares